The Effects of Ellagic Acid on Arylamine N-Acetyltransferase Activity in the Bacterium Pseudomonas Aeruginosa

References

• Wargovich M. J. Experimental evidence for cancer preventive elements in foods. Cancer Letters (1997); 114: 11–17
   PubMed Web of Science ®Google Scholar
• Rao C. V., Tokumo K., Rigotty J., Zang E., Kelloff G., Reddy B. S. Chemoprevention of colon carcinogenesis dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Research (1991); 51: 4528–4534
   PubMed Web of Science ®Google Scholar
• Akagi K., Hirose M., Hoshiya T., Mizoguchi Y., Ito N., Shirai T. Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Letters (1995); 94: 113–121
   PubMed Web of Science ®Google Scholar
• Mandal S., Stoner G. D. Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis (1990); 11: 55–61
   PubMed Web of Science ®Google Scholar
• Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., Mori H. Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis (1993); 14: 1321–1325
   PubMed Web of Science ®Google Scholar
• Mukhtar H., Das M., Bickers D. R. Inhibition of 3-methylcholanthrene-induced skin tumorigenicity in BALB/c mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. Cancer Research (1986); 46: 2262–2265
   PubMed Web of Science ®Google Scholar
• Wilson T., Lewis M. J., Cha K. L., Gold B. The effect of ellagic acid on xenobiotic metabolism by cytochrome P-450IIE1 and nitrosodimethylamine mutagenicity. Cancer Letters (1992); 61: 129–134
   PubMed Web of Science ®Google Scholar
• Ahn D., Putt D., Kresty L., Stoner G. D., Fromm D., Hollenberg P. F. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis (1996); 17: 821–828
   PubMed Web of Science ®Google Scholar
• Chang F. C., Chung J. G. Evidence for arylamine N-acetyltransferase in the bacterium. Escherichia coli, Current Microbiology (1998); 36: 125–130
   Google Scholar
• Mattano S. S., Weber W. W. Kinetics of arylamine N-acetyltransferase in tissues from rapid and slow acetylator mice. Carcinogenesis (1987); 8: 133–137
   PubMed Web of Science ®Google Scholar
• Grant D. M., Blum M., Beer M., Meyer U. A. Monomorphic and polymorphic human arylamineN-acetyltransferase: a comparison of liver isozymes and expressed products of two cloned genes. Molecular Pharmacology (1991); 39: 184–191
   PubMed Web of Science ®Google Scholar
• Hein D. W., Doll M. A., Rustan T. D., Gray K., Feng Y., Ferguson R. J., Grant D. W. Metabolic activation and detoxication of arylamine carcinogens by recombinant human NAT1 and NAT2 acetyltransferases. Carcinogenesis (1993); 14: 1633–1638
   PubMed Web of Science ®Google Scholar
• Weber W. W., Hein D. W. N-acetylation pharmacogenetics. Pharmacological Reviews (1985); 37: 25–79
   PubMed Web of Science ®Google Scholar
• Bell D. A., Stephens E. A., Castranio T., Umbach D. M., Watson M., Deakin M., Elder J., Hendricks C., Duncan H., Strange R. C. Polyadenylation polymorphism in the acetyltransferase 1 gene (NATl) increases risk of colorectal cancer. Cancer Research (1995); 55: 3537–3542
   PubMed Web of Science ®Google Scholar
• Roberts-Thomson I. C, Ryan P., Khoo K. K., Hart W. J., McMichael A. J., Butler R. N. Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet (1996); 347: 1372–1374
   PubMed Web of Science ®Google Scholar
• Watanabe M., Ishidate M., Nohmi T. Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of S. typhimurium tester strains possessing elevated O-acetyltransferase levels. Mutation Research (1990); 234: 337–348
   PubMed Web of Science ®Google Scholar
• Okumura F., Ueda O., Kitamuru S., Tatsumi K. N-acetylation and N-formylation of carcinogenic arylamines and related compounds in dogs. Carcinogenesis (1995); 16: 71–76
   PubMed Web of Science ®Google Scholar
• Lo H. H., Yen Y. S., Hsieh S. E., Chung J. G. Clycyrrhizic acid inhibits arylamine Af-acetyltransferase in Klebsiella pneumoniae. Journal of Applied Toxicology (1997); 17: 385–390
   PubMed Web of Science ®Google Scholar
• Wakabayashi K., Nagao M., Esumi H., Sugimura T. Food-derived mutagens and carcinogens. Cancer Research (1992); 52: 2092s–2098s
   PubMed Web of Science ®Google Scholar
• Hsieh S. E., Lo H. H., Chung J. G. The characteristics of arylamine N-acetyltransferase in Pseudomonas aeruginosa. Current Microbiology (1998); 36: 353–360
   PubMed Web of Science ®Google Scholar
• Cleland W. W. The statistical analysis of enzyme kinetics data. Advances in Enzymology and Related Areas of Molecular Biology (1967); 29: 1–32
   PubMedGoogle Scholar
• Watanabe M., Sofuni T., Nohmi T. Involvement of Cys69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: Sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S typhimurium and higher organisms. Journal of Biological Chemistry (1992); 267: 8429–8436
   PubMed Web of Science ®Google Scholar
• Chung J. G., Lo H. H., Hsieh S. E., Yen Y. S. Ibuprofen inhibits arylamine N-acetyltransferase in Klebsiella pneumoniae. Current Microbiology (1997); 34: 195–200
   Google Scholar
• Hsieh S. E., Lo H. H., Yen Y. S., Chung J. G. The effect of vitamin C on N-acetyltransferase activity in Klebsiella pneumoniae. Food and Chemical Toxicology (1997); 35: 1151–1157
   PubMed Web of Science ®Google Scholar